How AI is reshaping biotech through partnerships, from drug discovery to clinical trials, and what it means for the future of ...

In the assessment of 12-month price targets, analysts unveil insights for BioNTech, presenting an average target of $138.7, a ...

OraSure Technologies trades below liquidation value despite having multiple identifiable catalysts on the horizon. Read why I ...

In another signal of downgraded support for COVID-19 vaccination programmes under the Trump administration, the CDC has ...